Medical/Pharmaceuticals

WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group

SUZHOU, China, March 18, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced it has entered into a purchase agreement with CBC Group ("CBC"), a healthcare-dedicated investment firm, and other compani...

2021-03-18 08:59 4077

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software

PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ -- Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige's comprehensive portfo...

2021-03-18 01:02 2103

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim,France. With the € 25 million investment, the company is accelerating its European expansion plans for this key...

2021-03-17 23:40 3742

Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells

BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...

2021-03-17 20:00 1661

New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis

AUSTIN, Texas, March 17, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working ...

2021-03-17 20:00 5735

111, Inc. Enters into First-Ever Strategic Partnership with BeiGene

SHANGHAI, March 17, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, announced today it has entered into a strategic cooperation agreem...

2021-03-17 18:50 4966

WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China

HANGZHOU, China, March 17, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has entered into an equity agreement with Pfizer China ("Pfizer") to acquire its state-of-the-art biologics manu...

2021-03-17 08:45 4656

Cambridge Infinitus Research Centre Made New Research Progress

GUANGZHOU, China, March 17, 2021 /PRNewswire/ -- In 2015, Infinitus co-established Cambridge Infinitus Research Centre with theUniversity of Cambridge. Following five years of great collaboration, the two parties have recently renewed the contract for further exploration. Since its establishment...

2021-03-17 08:00 2675

Transcenta Continues to Push the Boundary of Cell Culture Productivity by Achieving > 6 g/L PER Day Volumetric Productivity in Continuous Perfusion Platform

SUZHOU and HANGZHOU, China, March 16, 2021 /PRNewswire/ -- Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced a major breakthrough in its continuous perfusion cell culture p...

2021-03-17 08:00 1817

EDAN Announces 2020 Annual Results and 2025 Outlook: Revenues Increased 104.1%

SHENZHEN, China, March 16, 2021 /PRNewswire/ -- EDAN Instruments, Inc.  ("EDAN" or the "Company) (SHE: 300206) on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its ...

2021-03-16 21:37 4659

The remarkable rise of Meenaxi Research Inc.

EDISON, N.J., March 16, 2021 /PRNewswire/ -- Mr. Kaushik Gandhi, the founder of Meenaxi Research Inc. is a pioneer in herbal and allopathic dermatological research. His start-up's unique formulation for atopic dermatitis, has etched an innovative pathway in the medical research industry. Mr. Gan...

2021-03-16 21:00 2670

U-Smell-It LLC Honored in Global $6M XPRIZE Rapid COVID Testing Competition

GUILFORD, Conn., March 16, 2021 /PRNewswire/ -- U-Smell-It™ LLC, a Guilford -based company specializing in innovative COVID detection techniques, has announced that it has won the$6M XPRIZE Rapid COVID Testing, a global effort to develop breakthrough COVID testing methods. XPRIZE Rapid COVID Test...

2021-03-16 21:00 1943

Apollo Hospitals, India becomes the first Asian Hospital to perform four consecutive MitraClip procedures in a day

CHENNAI, India, March 16, 2021 /PRNewswire/ -- The Apollo Hospitals group, one ofAsia's largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive MitraClip procedures in one day. The MitraClip implants were carried out on four pati...

2021-03-16 20:58 3438

Market of TCM Lianhua Qingwen Enlarged with Kenya's Approval

SHIJIAZHUANG, China, March 16, 2021 /PRNewswire/ -- In an announcement published by Yiling Pharmaceutical on Tuesday, it is disclosed the enterprise has received the herbal product license for Lianhua Qingwen Capsules from the Pharmacy and Poisons Board of the Ministry of Health ofKenya. Kenya i...

2021-03-16 20:20 2183

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction ...

2021-03-16 16:30 3576

Merck Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer

Not intended for US-, Canada- or UK-based media DARMSTADT, Germany, March 16, 2021 /PRNewswire/ -- Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of ...

2021-03-16 15:00 3261

Sihuan Pharmaceutical (0460.HK): 'A Friend of Time' 2021 - The Turning-point Year

HONG KONG, March 16, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal role in China's domestic medical industry and is a leading company for the development of the country's cardio-cerebral vascular prescription drugs. According to IMS data in 2018, Sihuan Pharmaceut...

2021-03-16 14:48 4613

QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines

Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...

2021-03-16 06:35 3131

CBC Group Announces the Appointment of Roger Perlmutter as Science Partner

SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce that Roger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman, Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Bo...

2021-03-15 22:00 3439

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 3672
1 ... 626627628629630631632 ... 646

Week's Top Stories